English 中国科学院 联系我们  
 
站内检索
机构概况
机构简介   现任领导
历任领导   学术委员会
学位委员会   组织机构
两院院士   历史沿革
园区风貌   历年年报
人才招聘  
药理学第二研究室
研究室简介
冯林音研究组
刘景根研究组
章海燕研究组
李扬研究组
 您现在的位置:首页 > 机构设置 > 研究机构 > 研究室 > 药理学第二研究室 > 章海燕研究组
章海燕研究组
章海燕研究组

中国科学院院士1名、研究员1名、助理研究员1名、实验师3名、硕/博士研究生9名。 

 

 

主要从事阿尔采末症(Alzheimer’s disease)、血管性痴呆(Vascular dementia)以及缺血性脑卒中的发病机制和治疗策略研究。近年来致力于开展针对胆碱能系统缺损假说的关键问题——胆碱能系统昼夜节律需求乙酰胆碱酯酶抑制剂病患亚群反应差异性和外周胆碱能不良反应普遍性和针对级联反应假说的核心理论——“Aβ寡聚体毒性细胞内及细胞器内毒性的抗痴呆药物新靶标发现和创新药物研究,以及针对缺血性脑卒中开展新型活性天然产物和SIRTPSD95-nNOS等靶向型药物研究。 

 

 


 

Trends PharmacolSci, Neurobiol Aging, Free RadicBiol& Med, J Alzheimer DisSCI期刊上发表论文58篇,申请专利14项,授权专利4项。 

 

 

  1. GuoXJ, Tian XS, Ruan Z, Chen YT, Wu L, Gong Q, Wang W, Zhang HY*. Dysregulation of Neurotrophic and Inflammatory Systems Accompanied by Decreased CREB Signaling in Ischemic Rat Retina. Exp Eye Res 2014 Jun 19;125C:156-163.
  2. Tian XS, GuoXJ, Ruan Z, Lei Y, Chen YT, Wu L, Gong Q, Wang W, Zhang HY*. Long-term vision and non-vision dominant behavioral deficits in the 2-VO rats are accompanied by time and regional glial activation in the white matter. PLos one 2014 Jun 26;9(6):e101120.
  3. Huang XT, Qian ZM, He X, Gong Q, Wu KC, Jiang LR, Lu LN, Zhu ZJ, Zhang HY, Yung WH, Ke Y. Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease. Neurobiol Aging. 2014; 35: 1045-54.
  4. Tao YM, Fang L, Yang YM, Jiang HL, Yang HY, Zhang HY*, Zhou H*. Quantitative proteomic analysis reveals the neuroprotective effects of huperzine A for amyloid beta treated neuroblastomaN2a cells. Proteomics. 2013; 13(8): 1314-24.
  5. Xing WQ, Fu Y, Shi ZX, Lu D, Zhang HY*, Hu YH*. Discovery of novel 2,6-disubstitutedpyridazinone derivatives as acetylcholinesterase inhibitors. Eur J Med Chem. 2013; 63: 95-103.
  6. ZouYQ, Xu L, Chen WY, Zhu YP, Chen TT, Fu Y, Li L, Ma LP, Xiong B, Wang X, Li J, He JH, Zhang HY*, Xu YC*, Li J*, Shen JK*. Discovery of pyrazole as C-terminus of selective BACE1 inhibitors. Eur J Med Chem. 2013; 68: 270-83.
  7. Zhang B, Tang XC, Zhang HY*. Alternations of central insulin-like growth factor-1 sensitivity in APP/PS1 transgenic mice and neuronal models. J Neurosci Res. 2013; 91(5): 717-25.
  8. GuoXJ, Chen YT, Liu QF, Wu J, Wang LY, Tang XC, Zhao WM*, Zhang HY*. Ac-cel, a novel antioxidant, protects against hydrogen peroxide-induced injury in PC12 cells via attenuation of mitochondrial dysfunction. J MolNeurosci. 2013; 50(3): 453-61.
  9. Wang LY, Wu J, Yang Z, Wang XJ, Fu Y, Liu SZ, Wang HM, Zhu WL, Zhang HY*, Zhao WM*. (M)- and (P)-bicelaphanol A, dimerictrinorditerpenes with promising neuroprotective activity from Celastrusorbiculatus. J Nat Prod. 2013; 76: 745-9.
  10. Wang XJ, Wang LY, Fu Y, Wu J, Tang XC, Zhao WM, Zhang HY*. Promising effects on ameliorating mitochondrial function and enhancing Akt signaling in SH-SY5Y cells by (M)-bicelaphanol A, a novel dimericpodocarpane type trinorditerpene isolated from Celastrusorbiculatus. Phytomedicine. 2013; 20(12):1064-70.
  11. Liang LF, Wang XJ, Zhang HY, Liu HL, Li J, Lan LF, Zhang W, GuoYW. Bioactive polyhydroxylated steroids from the Hainan soft coral SinulariadepressaTixier-Durivault. Bioorg Med ChemLett. 2013; 23(5): 1334-7.
  12. Tang Y, Fu Y, Xiong J, Li M, Ma GL, Yang GX, Wei BG, Zhao Y, Zhang HY, Hu JF. Casuarinines A-J, lycodine-type alkaloids from Lycopodiastrumcasuarinoides. J Nat Prod. 2013; 76(8): 1475-84.
  13. Yang L, Ye CY, Huang XT, Tang XC, Zhang HY*. Decreased accumulation of subcellular amyloid-β with improved mitochondrial function mediates the neuroprotective effect of huperzine A. J Alzheimers Dis. 2012; 31(1): 131-42.
  14. Gao X, Zheng CY, Qin GW, Tang XC, Zhang HY*. S-52, a novel nootropic compound, protects against β-amyloid induced neuronal injury by attenuating mitochondrial dysfunction. J Neurosci Res. 2012; 90(10): 1981-8.
  15. Wang Y, Tang XC, Zhang HY*. Huperzine A alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice. J Neurosci Res. 2012; 90: 508-17.
  16. Zhang HY*. New insights into huperzine A for the treatment of Alzheimer's disease. ActaPharmacol Sin. 2012; 33: 1170-5.
  17. Jiang CS, GuoXJ, Gong JX, Zhu TT, Zhang HY*, GuoYW. Synthesis and biological evaluation of 21-arylidenepregnenolone derivatives as neuroprotective agents. Bioorg Med ChemLett. 2012; 22: 2226-9.
  18. Chen BE, Ye F, Yu L, JiaGF, Huang XT, Zhang XJ, Peng SY, Chen K, Wang MN, Gong SZ, Zhang RH, Yin JY, Li HY, Yang YM, Liu H, Zhang JW, Zhang HY, Zhang A, Jiang HL, Luo C, Yang CG. Development of Cell-Active N(6)-Methyladenosine RNA DemethylaseFTO Inhibitor. J Am Chem Soc. 2012; 134: 17963-71.
  19. Dong K, Pu JX, Zhang HY, Du X, Li XN, Zou J, Yang JH, Zhao W, Tang XC, Sun HD. Dibenzocyclooctadienelignans from Kadsurapolysperma and their antineurodegenerative activities. J Nat Prod. 2012; 75: 249-56.
  20. Yao LG, Zhang HY, Liang LF, GuoXJ, Mao SC, GuoYW. Yalongenes A and B, Two New Cembranoids with Cytoprotective Effects from the Hainan Soft Coral SarcophytontrocheliophrumMarenzeller. Helv. Chim. Acta. 2012; 95: 235-9.
  21. Chen HD, Ding YQ, Yang SP, Li XC, Wang XJ, Zhang HY, Ferreira D, Yue JM. Morusalbanol A, a neuro-protective Dielse-Alder adduct with an unprecedented architecture from Morusalba. Tetrahedron. 2012; 68: 6054-8.
  22. Yang JH, Zhang HY, Wen J, Du X, Chen JH, Zhang HB, Xiao WL, Pu JX, Tang XC, Sun HD. Dibenzocyclooctadienelignans with antineurodegenerative potential from Kadsuraananosma. J Nat Prod.2012; 74: 1028-35.
  23. Wang Y, Yang YS, Tang XC, Zhang HY*. T33, a novel peroxisome proliferator-activated receptor γ/α agonist, exerts neuroprotective action via its anti-inflammatory activities. ActaPharmacol Sin. 2011; 32: 1100-8.
  24. Wang JR, Liu HL, Kurtán T, Mándi A, Antus S, Li J, Zhang HY, GuoYW. Protolimonoids and norlimonoids from the stem bark of Toonaciliata var. pubescens. Org BiomolChem.2011; 9: 7685-96.
  25. Yang JH, Zhang HY, Du X, Wang W, Xiao WL, Wen J, Pu JX, Tang XC, Sun HD. New dibenzocyclooctadienelignans from the Kadsuraananosma. Tetrahedron. 2011; 67: 4498-504.
  26. Wang J, Zhang HY*, Tang XC. Huperzine A Improves Chronic Inflammation and Cognitive Decline in Rats With Cerebral Hypoperfusion. J Neurosci Res. 2010; 88: 807-15.
  27. Wang Y, Huang LQ, Tang XC, Zhang HY*. Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia. ActaPharmacol Sin. 2010; 31(6): 649-64.
  28. Shi YF, Zhang HY*, Wang W, Fu Y, Xia Y, Tang XC, Bai DL, He XC. Novel 16-substituted bifunctional derivatives of huperzine B: multifunctional cholinesterase inhibitors. ActaPharmacol Sin. 2009; 30(8): 1195-203.
  29. Gao X, Zheng CY, Yang L, Tang XC, Zhang HY*. HuperzineA Protects Isolated Rat Brain Mitochondria against β-Amyloid Peptide. Free Radical Biol& Med. 2009; 46(11): 1454-62.
  30. Zhu YP, Xiao K, Ma LP, Xiong B, Fu Y, Yu HP, Wang W, Wang X, Hu DY, Peng HL, Li JY, Gong Q, Chai Q, Tang XC, Zhang HY*, Li J, Shen JK. Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and b-secretase. Bioorgan Med Chem. 2009; 17(4): 1600-13.
  31. Wang J, Zhang HY, Tang XC. Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment. ActaPharmacol Sin. 2009; 30: 879-88.
  32. Yuan T, Yang SP, Zhang HY, Liao SG, Wang W, Wu Y, Tang XC, Yue JM. Phenolic compounds with cell protective activity from the fruits of Livistonachinensis. J Asian Nat Prod Res. 2009; 11(3):243-9.
  33. Zhu YP, Xiao K, Yu HP, Ma LP, Xiong B, Zhang HY, Wang X, Li JY, Li J, Shen JK. Discovery of potent beta-secretase (bace-1) inhibitors by the synthesis of isophthalamide-containing hybrids. ActaPharmacol Sin. 2009; 30(2): 259-69.
  34. Zhu Q, Tang CP, KeCQ, Wang W, Zhang HY, Ye Y. Sesquiterpenoids and Phenylpropanoids from Pericarps of Illiciumoligandrum. J Nat Prod. 2009; 72: 238-42.

 

 

研究室组织结构

  

  版权所有 中国科学院上海药物研究所 沪ICP备05005386号-1
地址: 上海市浦东张江祖冲之路555号 邮编:201203 电话: 86-21-50806600

沪公网安备 31011502008305号